A Phase 1a "Window Trial" on Cannabidiol (CBD) for Breast Cancer Primary Tumors

Date Added
January 20th, 2026
PRO Number
Pro00148581
Researcher
Nancy DeMore

List of Studies


Keywords
Cancer/Breast
Summary

This study is for adults with invasive breast cancer who are scheduled to have surgery of the breast. The purpose of the study is to determine whether cannabidiol (CBD) helps to slow the growth or cancer cells and whether or not taking CBD during the waiting period before surgery reduces anxiety. Participation in this study will last approximately 56 days.

Institution
MUSC
Recruitment Contact
HCC Clinical Trials Office
843-792-9321
hcc-clinical-trials@musc.edu



-- OR --